Literature DB >> 7746293

Growth inhibition of pathogenic yeasts by Pseudomonas aeruginosa in vitro: clinical implications in blood cultures.

R Grillot1, V Portmann-Coffin, P Ambroise-Thomas.   

Abstract

The interaction between yeasts and bacteria may have clinical implications in polymicrobial septicaemia. The in vitro effect of Pseudomonas aeruginosa on five pathogenic yeast species, Candida albicans, Candida tropicalis, Candida parapsilosis, Candida glabrata and Cryptococcus neoformans, was investigated. Yeast inhibition assays were performed in an aerobic blood culture medium, inoculated with yeast cells (inoculum 1-10 CFU ml-1) and bacterial cells (inoculum 10-10(7) CFU ml-1). Interactions between P. aeruginosa and yeasts were determined after incubation by enumeration of pure and mixed cultures. Growth of all isolates tested was completely or partially inhibited by P. aeruginosa in blood culture medium, the phenomenon depending on the yeast genus and bacterial inoculum. Suppression of fungal growth was also observed in bacterial culture filtrate. This in vitro antifungal activity may preclude yeast recovery from blood cultures in mixed infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7746293     DOI: 10.1111/myc.1994.37.9-10.343

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

1.  Use of simulated blood cultures to compare a specific fungal medium with a standard microorganism medium for yeast detection.

Authors:  H Fricker-Hidalgo; F Chazot; B Lebeau; H Pelloux; P Ambroise-Thomas; R Grillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

Review 2.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

3.  Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.

Authors:  H M H N Bandara; J Y Y Yau; R M Watt; L J Jin; L P Samaranayake
Journal:  BMC Microbiol       Date:  2010-04-25       Impact factor: 3.605

4.  Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system.

Authors:  Marie-Hélène Meyer; Valérie Letscher-Bru; Benoît Jaulhac; Jocelyn Waller; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media.

Authors:  Alfredo Chiarini; Angelo Palmeri; Teresa Amato; Rita Immordino; Salvatore Distefano; Anna Giammanco
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

6.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections.

Authors:  S-H Kim; Y K Yoon; M J Kim; J W Sohn
Journal:  Clin Microbiol Infect       Date:  2012-06-01       Impact factor: 8.067

7.  Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.

Authors:  Eduardo Lopez-Medina; Di Fan; Laura A Coughlin; Evi X Ho; Iain L Lamont; Cornelia Reimmann; Lora V Hooper; Andrew Y Koh
Journal:  PLoS Pathog       Date:  2015-08-27       Impact factor: 6.823

8.  Pseudomonas aeruginosa inhibits the growth of pathogenic fungi: In vitro and in vivo studies.

Authors:  Lingqing Xu; Feng Wang; Yin Shen; Hongyan Hou; Weiyong Liu; Cailin Liu; Cui Jian; Yue Wang; Mingyue Sun; Ziyong Sun
Journal:  Exp Ther Med       Date:  2014-03-21       Impact factor: 2.447

9.  Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts.

Authors:  Ling-Qing Xu; Jian-Wen Zeng; Chong-He Jiang; Huan Wang; Yu-Zhen Li; Wei-Hong Wen; Jie-Hua Li; Feng Wang; Wei-Jen Ting; Zi-Yong Sun; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

10.  Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa.

Authors:  Alexandra Brand; Julia D Barnes; Kevin S Mackenzie; Frank C Odds; Neil A R Gow
Journal:  FEMS Microbiol Lett       Date:  2008-08-02       Impact factor: 2.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.